Navigation Links
Bausch & Lomb Launches Multi-Tiered U.S. Consumer Education Initiative to Raise Awareness of Presbyopia
Date:3/12/2009

yndicated programs such as Oprah, Ellen, The Martha Stewart Show, Live With Regis and Kelly, and The View.
  • The TV campaign will be backed by an integrated online awareness building campaign, with a variety of placements on sites such as HGTV, Food Network, Oprah, Real Age, and Rachael Ray.
  • All of the advertising is scheduled to run throughout 2009.

    • Website

    • At www.goodbyereaders.com, which launched this month, consumers can find information about presbyopia and multifocal contact lenses.
    • Bausch & Lomb's new online lens demonstration provides consumers with a visual illustration of how the Bausch & Lomb Multi-Focal lens design works. Consumers can see how their eyes adjust to near, intermediate, and far distances using the gradual transition of their Multi-Focal contact lenses.
    • Consumers can find a local doctor, if they don't already have one, by using the new doctor locator, as well as download a free trial certificate.

    Consumer Promotion

    • To increase consumer engagement and awareness, an online promotion entitled, "See a New You" will launch on www.goodbyereaders.com on March 23rd, highlighting the fashion and lifestyle benefits of multi-focal contact lenses.
    • Users can take fashion and style quizzes, as well enter to win a personal lifestyle makeover and a year's supply of Bausch & Lomb Multi-Focal contact lenses.

    With an innovative optical design, Bausch & Lomb PureVision(R) Multi-Focal contact lenses are designed to allow users to see clearly at all distances -- near, far, and everywhere in-between. Bausch & Lomb's PureVi
    '/>"/>

    SOURCE Bausch & Lomb
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3

    Related medicine news :

    1. Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development
    2. Bausch & Lomb Survey Shows People with Astigmatism Unaware of Contact Lens Options
    3. Bausch & Lombs Crystalens to be Featured in Florida Advertising Campaign.
    4. Bausch & Lomb Names Peter Valenti, III, as President, North America, Vision Care
    5. Home Care Delivered, Inc. Launches Proprietary Insurance Payer Management System
    6. 23andMe Launches Parkinsons Disease Genetics Initiative
    7. CSC Launches New Enterprise Data Loss Prevention Service
    8. Perot Systems Launches Webinar Series and Website Resources on Healthcare Stimulus Plan Provisions
    9. RWJF launches $19 million public health law research program
    10. Use of Avastin and Erbitux in the Adjuvant Setting and Launches of Emerging Agents Will Drive the Colorectal Cancer Drug Market to $7.8 Billion in 2017
    11. SynergEyes(R) Launches a New Website for Keratoconus Patients

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/2/2009)...e, many more to come, NIH director says, , ...een stem cell lines have been added to the pool th..., and many more such lines will soon be made avail..., These are the first additional embryonic stem .... National Institutes of Health (NIH) since Presid...
    (Date:12/2/2009).... 2 In the wake of the ...minated with a plastics chemical linked to birth d...ately to protect infants and mothers. ,, The Ho...nol A, or BPA, in food and beverage containers. Th...d Rep. Edward Markey of Massachusetts, would prote...
    (Date:12/2/2009).../PRNewswire/ - As part of its continued commitment... part of Pfizer, has pledged more than 40 million ...o the World Federation of Hemophilia (WFH). This i...nitarian Aid Program, and will make a significant ...ation will directly support building sustainable n...
    (Date:12/2/2009)...y federal government ends nine months of obstructi...RNewswire-USNewswire/ -- More than 2,300 healthcar...ilities across Southern California will soon vote ...Healthcare Workers (NUHW). ,, A majority of the... but SEIU delayed the election by filing frivolous...
    (Date:12/2/2009)...oves sports. An avid tennis player and golfer, as ...ent became increasingly frustrated over time as hi...ve eye disorder. Unable to return the tennis ball ...ospect of a corneal transplant to restore his visi...oni discovered an alternative treatment. He receiv...
    Breaking Medicine News(10 mins):Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3Health News:Pre-Polluted Babies: Congress Must Act to Protect Infants, Moms from Toxic Plastics Chemical BPA 2Health News:The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH 2Health News:Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers 2Health News:Brandeis studies evaluate visionary approach to improving eyesight 2
    ...A mysterious post-operative eye ailment that swept...the cataract-surgery unit in Scarborough Hospital,...ek. // The Hospital, which performs around 5,0...nown as toxic anterior segment syndrome, or TASS. ...
    ...People working at call centres could suffer hearin...// Acoustic shocks are temporary or permanen... the nervous system, which may be caused to the us...cted noise. Two thirds of call centres in Britain ...
    ...Last May, two animal caretakers sent letters to ci.... government lab's disposal procedures were not st...at died of infectious diseases such as mad cow and...cials to study the issue at length. The eight-pers...
    ...A New Zealand woman who travelled to China for ste...s of her husband, Rein. She was 66. // Willie...or neurone disease in 2004.She left her home in Ro...y that aids speaking, breathing and swallowing. ...
    ...Patients with dementia have been benefited by occu... perform tasks around the house thereby //improvin...o recent research. Dementia such as Alzheimer'...es, current drugs do not improve the symptoms of d...
    ...An alert over potential outbreak of 'Legionnaires ...r 500 guests who visited the Grand Atlantic Hotel ...by the health officials after water samples tested...nnaires disease is caused by the bacterium Legione...
    Other Medicine News:Health News:Eye Surgeries Remain Cancelled Due To TASS Outbreak In Toronto 2Health News:Complaints Against US Federal lab Over-ruled by Panel 2Health News:Task therapy Beneficial to Patients with Dementia 2
    (Date:12/1/2009)...RK, Dec. 1 Reportlinker.com announ... in its catalogue: ,, Medical Oxygen Systems ...reportlinker.com/p0164334/Medical-Oxygen-Systems--... medical oxygen systems market for home healthcare...s. The buoyant growth expectations stem from demog...
    (Date:12/1/2009)...N.J., Dec. 1 Johnson & Johnson... announced today that it has submitted a New Drug ...stration (FDA) for tapentadol extended release (ER...he management of moderate to severe chronic pain i...c pain, defined as pain that persists for long per...
    (Date:12/1/2009)...STATION, N.J., Dec. 1 Merck & ...rug Administration (FDA) has approved ZEGERID OTC(...apsules), for over-the-counter treatment of freque...he-counter by Schering-Plough HealthCare Products,...amp; Co., Inc. Schering-Plough and Merck merged on...
    Breaking Medicine Technology:Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 2New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 3New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 4New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 5New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 7FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Interventional radiology resources cover peripheral arterial disease 56584 1Interventional radiology resources cover peripheral arterial disease 56584 2Interventional radiology resources cover peripheral arterial disease 56584 3Toward a nanomedicine for brain cancer 9839 1ACLA Opposes Proposed LabTax 56582 1ACLA Opposes Proposed LabTax 56582 2
    ... by Medical Research Council, LEXINGTON, Mass., A...EV ) announced today the completion of,enrollment ... PRO 2000, the,Company,s candidate vaginal microbi...transmitted infections. The trial is sponsored by ...) and conducted by the Microbicides,Development Pr...
    ...ciences, Inc. (Nasdaq: HGSI ) today announced tha...ng of patients in a randomized Phase 2 trial of,HG...therapy agents,paclitaxel and carboplatin as first...er (NSCLC)., (Logo: http://www.newscom.com/cgi-b...medical need for effective treatment options for,n...
    Other Medicine Technology:Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5
    ... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
    ... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
    ... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
    ... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
    Medicine Products: